Nu Skin Enterprises Inc (NUS)
Return on total capital
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 48,268 | 59,664 | 65,745 | 74,766 | 110,847 | 103,707 | 189,375 | 223,224 | 233,992 | 302,370 | 311,214 | 283,912 | 257,564 | 223,546 | 219,210 | 235,338 | 267,426 | 231,178 | 241,961 | 250,523 |
Long-term debt | US$ in thousands | 478,040 | 362,896 | 367,753 | 372,609 | 377,466 | 382,323 | 387,179 | 258,995 | 268,781 | 278,563 | 288,343 | 298,120 | 305,393 | 312,664 | 319,932 | 327,197 | 334,461 | 341,724 | 348,986 | 356,247 |
Total stockholders’ equity | US$ in thousands | 821,968 | 822,187 | 895,345 | 892,970 | 897,296 | 841,934 | 941,035 | 934,200 | 912,772 | 936,477 | 917,826 | 871,474 | 894,271 | 827,473 | 792,012 | 800,498 | 875,289 | 845,800 | 834,950 | 811,195 |
Return on total capital | 3.71% | 5.03% | 5.21% | 5.91% | 8.70% | 8.47% | 14.26% | 18.71% | 19.80% | 24.89% | 25.80% | 24.27% | 21.47% | 19.61% | 19.71% | 20.87% | 22.11% | 19.47% | 20.44% | 21.46% |
December 31, 2023 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $48,268K ÷ ($478,040K + $821,968K)
= 3.71%
The return on total capital for Nu Skin Enterprises, Inc. has exhibited a decreasing trend over the past eight quarters. It decreased from 21.11% in Q1 2022 to 5.10% in Q4 2023. This decline indicates a potential inefficiency in the utilization of the company's capital resources to generate profit. It is essential for the company to focus on improving its operational efficiency and profitability in order to enhance its return on total capital in the future.
Peer comparison
Dec 31, 2023
Company name
Symbol
Return on total capital
Nu Skin Enterprises Inc
NUS
3.71%
Cardinal Health Inc
CAH
—
Cencora Inc.
COR
49.64%
McKesson Corporation
MCK
—